Authors: | Koh, W. J.; Greer, B. E.; Abu-Rustum, N. R.; Apte, S. M.; Campos, S. M.; Chan, J.; Cho, K. R.; Cohn, D.; Crispens, M. A.; DuPont, N.; Eifel, P. J.; Fader, A. N.; Fisher, C. M.; Gaffney, D. K.; George, S.; Han, E.; Huh, W. K.; Lurain, J. R. 3rd; Martin, L.; Mutch, D.; Remmenga, S. W.; Reynolds, R. K.; Small, W. Jr; Teng, N.; Tillmanns, T.; Valea, F. A.; McMillian, N.; Hughes, M. |
Article Title: | Uterine neoplasms, version 1.2014 |
Abstract: | Adenocarcinomaof the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uterine cancer cases will occur in 2013, with 8190 deaths resulting from the disease. Uterine sarcomas (stromal/mesenchymal tumors) are uncommon malignancies, accounting for approximately 3% of all uterine cancers. The NCCN Guidelines for Uterine Neoplasms describe malignant epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management. This excerpt of these guidelines focuses on earlystage disease. © JNCCN-Journal of the National Comprehensive Cancer Network. |
Keywords: | cancer chemotherapy; cancer surgery; cancer risk; united states; cancer adjuvant therapy; cancer radiotherapy; cancer staging; antineoplastic agent; cancer diagnosis; endometrium carcinoma; endometrium cancer; practice guideline; oncology; clinical evaluation; uterus cancer; uterus sarcoma; hormone substitution; female genital system; human; article |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 12 |
Issue: | 2 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2014-02-01 |
Start Page: | 248 |
End Page: | 280 |
Language: | English |
PROVIDER: | scopus |
PUBMED: | 24586086 |
DOI/URL: | |
Notes: | Export Date: 1 August 2014 -- Source: Scopus |